HealthQuill JN.1 Variant
The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared to two weeks prior, according to the National Public Health Agency.
Drugs Health Pharma

JN.1 sub-variant Covid-19 cases rise to 62% in the US, says CDC 

HQ Team January 8, 2023: The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared.

Read More
Remember that Covid-19 is still with us, continuously evolving and forming new lineages and we still need to stay ahead of it. Maintaining a cautious vigilance rather than undue panic is the need of the day.
Drugs Health Pharma

Opinion: Covid-19 variant needs cautious vigilance, not undue panic

By K. Leelamoni The coronavirus variant JN. 1 has been causing concern among health experts and the public alike. JN.1 is surging in.

Read More
X